BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11127303)

  • 1. The kinetics of CD154 (CD40L) expression in peripheral blood mononuclear cells of healthy subjects in liver allograft recipients and X-linked hyper-IgM syndrome.
    Bartlett A; McCall J; Ameratunga R; Munn S
    Clin Transplant; 2000 Dec; 14(6):520-8. PubMed ID: 11127303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Yeong ML; Benjamin CD; Hess D; Peach R; Munn SR
    Liver Transpl; 2002 May; 8(5):458-68. PubMed ID: 12004346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.
    Sho M; Sandner SE; Najafian N; Salama AD; Dong V; Yamada A; Kishimoto K; Harada H; Schmitt I; Sayegh MH
    Ann Surg; 2002 Nov; 236(5):667-75. PubMed ID: 12409674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen.
    Ampel NM; Christian L
    Med Mycol; 2000 Apr; 38(2):127-32. PubMed ID: 10817229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
    J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Ramadas R; Yeong ML; Benjamin CD; Hess D; Munn SR
    J Surg Res; 2003 Nov; 115(1):1-8. PubMed ID: 14572766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.
    Boix F; Millan O; San Segundo D; Mancebo E; Rimola A; Fabrega E; Fortuna V; Mrowiec A; Castro-Panete MJ; Peña Jde L; Llorente S; Minguela A; Bolarin JM; Paz-Artal E; Lopez-Hoyos M; Brunet M; Muro M
    Immunobiology; 2016 May; 221(5):595-603. PubMed ID: 26850323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
    Kirk AD; Harlan DM; Armstrong NN; Davis TA; Dong Y; Gray GS; Hong X; Thomas D; Fechner JH; Knechtle SJ
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8789-94. PubMed ID: 9238056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of inducible lymphocyte costimulatory molecules in human renal allograft.
    Biancone L; Segoloni G; Turello E; Donati D; Bussolati B; Piccoli G; Camussi G
    Nephrol Dial Transplant; 1998 Mar; 13(3):716-22. PubMed ID: 9550652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.
    Gaweco AS; Mitchell BL; Lucas BA; McClatchey KD; Van Thiel DH
    Kidney Int; 1999 Apr; 55(4):1543-52. PubMed ID: 10201021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection.
    Reul RM; Fang JC; Denton MD; Geehan C; Long C; Mitchell RN; Ganz P; Briscoe DM
    Transplantation; 1997 Dec; 64(12):1765-74. PubMed ID: 9422418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 ligand-deficient T cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability.
    Lobo FM; Scholl PR; Fuleihan RL
    J Immunol; 2002 Feb; 168(3):1473-8. PubMed ID: 11801691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of peripheral blood CD4 and CD8 lymphocyte subsets, CD69 expression and histologic rejection grade as diagnostic markers for the presence of cardiac allograft rejection.
    Creemers P; Brink J; Wainwright H; Moore K; Shephard E; Kahn D
    Transpl Immunol; 2002 Nov; 10(4):285-92. PubMed ID: 12507400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers.
    O'Gorman MR; Zaas D; Paniagua M; Corrochano V; Scholl PR; Pachman LM
    Clin Immunol Immunopathol; 1997 Nov; 85(2):172-81. PubMed ID: 9344700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome.
    Bhushan A; Barnhart B; Shone S; Song C; Covey LR
    J Immunol; 2000 Mar; 164(6):2871-80. PubMed ID: 10706672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
    Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
    Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.